Podcasts about fashp

Our guests: "Les Louden, PharmD, MS, Pharmacy Manager St. Joseph's Hospital BayCare Health System, and John B. Hertig, PharmD, MS, CPPS, FASHP, FFIP Founder, Hertig Healthcare Advising, Adjunct Assistant Professor, Purdue University.In this episode, I welcome back Dr. John Hertig along with first-time guest Les Louden from BayCare Health System to discuss their groundbreaking research on controlled substance waste in hospital procedural areas.Their recent study, ""Assessing the Costs of Intravenous Push Waste in Intraoperative Areas Through Observation,"" reveals striking findings about both the financial and operational impact of medication waste. We explore how commonly used medications like fentanyl, hydromorphone, morphine, midazolam, and ketamine are routinely wasted in significant quantities.John and Les discuss how their multi-site study quantified not just product waste but also the substantial ""workforce time waste"" associated with medication disposal processes. With an estimated $56,557 worth of medication and staff time wasted annually at just the hospitals studied, our conversation examines the practical implications for healthcare systems nationwide.We also delve into potential solutions, including automated workflows that significantly reduce documentation time, manufacturer considerations for right-sized medication packaging, and the patient safety implications when clinical staff are pulled away from care to witness waste disposal.Whether you're a healthcare administrator, pharmacy professional, or clinician, this evidence-based discussion offers valuable insights into an often overlooked aspect of healthcare efficiency and resource management.Thanks to our sponsor, MIDAS Healthcare SolutionsLearn more about V.I.E.W. Waste and Return System: https://midashs.com/products/For more information on Drug Diversion mitigation and resources, visit: https://www.rxpert.solutions/

Lisa S. Stump, BSPharm, MS, FASHP, Executive Vice President, Chief Digital Information Officer, and Dean of Information Technology at Mount Sinai Health System, discusses key areas of growth for the year, including advancements in AI and clinical innovation. She addresses anticipated challenges such as the rapid pace of change and transforming operating models, while sharing her strategies for setting the organization up for long-term success.

Lisa S. Stump, BSPharm, MS, FASHP, Executive Vice President, Chief Digital Information Officer, and Dean of Information Technology at Mount Sinai Health System, discusses key areas of growth for the year, including advancements in AI and clinical innovation. She addresses anticipated challenges such as the rapid pace of change and transforming operating models, while sharing her strategies for setting the organization up for long-term success.

It's Best-Of Week on The Academic Minute:  In today's segment, C. Michael White, distinguished professor and chair of pharmacy practice at the University of Connecticut School of Pharmacy, discussed a new treatment for those suffering from depression. Michael White, Pharm.D., FCP, FCCP, FASHP has ~500 publications resulting in 18288 citations with an H-index of 70; […]

Interviews with Leaders in Clinical Pharmacy: Stuart T. Haines, Pharm.D., FCCP, FAPhA, FASHP, BCACP, BCPS, incoming JACCP Editor-in-Chief

Leigh Briscoe-Dwyer, PharmD, BSPharm, BCPS, FASHP, serves as President of the American Society of Health-System Pharmacists (ASHP). She has also served in various organizations and professional societies in New York. We talk through her current presidential year with ASHP and her message of telling your stories that coincides with ASHP's ‘We Are Your Pharmacist' campaign. She is passionate about pharmacy and you'll hear the top issues she is focused on this year!

Explore the essential contributions of health-system pharmacists through engaging interviews with pharmacists and other healthcare team members who witness their impact firsthand. Nearly one in three pharmacists work beyond retail settings, bringing their specialized expertise in medications to hospitals, clinics, and outpatient facilities. As trusted partners on the healthcare team, these pharmacists work to ensure that medications are safe, effective, and accessible, playing a critical role in each patient's journey. Listen in as we uncover the many ways pharmacists make a difference.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Depression sufferers may have a new choice for treatment. C. Michael White, distinguished professor and chair of pharmacy practice at the University of Connecticut School of Pharmacy, explains. Michael White, Pharm.D., FCP, FCCP, FASHP has ~500 publications resulting in 18288 citations with an H-index of 70; placing him within an elite group of researchers. Dr. […]

Special guest Marshall E. Cates, PharmD, BCPP, FASHP, FCCP, FALSHP, Professor of Pharmacy Practice from the McWhorter School of Pharmacy at Samford University joins us to talk about pharmacotherapy for anxiety and depression.Listen in as we discuss pharmacotherapy for managing generalized anxiety disorder and major depression, with a focus on tailoring first- or second-line options to individual patient needs.You'll also hear practical advice from Craig D. Williams, PharmD, FNLA, BCPS, a member of TRC's Editorial Advisory Board and Clinical Professor of Pharmacy Practice at the Oregon Health and Science University.For the purposes of disclosure, Dr. Cates reports relevant financial relationships [psychiatry] with Biogen, Sage Therapeutics (honorarium); Otsuka (speakers bureau).The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.The clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter and Prescriber Insights: Chart: Pharmacotherapy of Anxiety Disorders in AdultsChart: Choosing and Switching AntidepressantsChart: Combining and Augmenting AntidepressantsIf you're not yet a Pharmacist's Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com. Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Trial of the Week: PROWESS-SHOCK Special Guest: Paul Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS @paulszumita   03:30 – Background studies/Setting the scene 30:25 – PROWESS-SHOCK discussion/Where are we now   Paul Szumita joins to highlight a June Trial of the Week “Drotrecogin alfa (activated) in adults with septic shock” published in the New England Journal of Medicine in 2012. To fully understand the discussion regarding drotrecogin alfa, Paul and I review the mechanism of action and its proposed action in the treatment of sepsis. Then we review earlier studies and the controversy behind the FDA approval process. Finally, we go into detail on what Clinical Pharmacists were tasked with doing at the time based on treatment protocols or hospital restrictions. Then we dive into the Trial of the Week, discussing the study design and results. What was the mood in ICUs and Pharmacy Departments after this publication? How much did our sepsis care improve from PROWESS to PROWESS-SHOCK? What lessons did we learn with the Xigris FDA approval process? Is there a patient population that could still benefit from drotrecogin alfa treatment? Plus, trial fun facts, issues with calculating APACHE II scores, and so much more. Reference list: https://pharmacytodose.com/wp-content/uploads/2024/06/prowess-shock-trial-of-the-week-references.pdf   PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Margins are tight everywhere in healthcare, and a health system pharmacy adds value especially when led by an established chief pharmacy officer.  Jordan Dow, Chief Pharmacy Officer at Froedtert Health, Michael Oinonen, VP of Pharmacy Networks at Vizient, and our usual host Gretchen Brummel, Pharmacy Executive Director for the Vizient Center for Pharmacy Practice Excellence join guest host Carolyn Liptak, Pharmacy Executive Director with the Vizient Center for Pharmacy Practice Excellence to discuss the importance of the CPO role.   Guest speakers:  Jordan Dow, PharmD, MS, FASHP, FACHE Chief Pharmacy Officer Froedtert Health   Michael Oinonen, PharmD VP of Pharmacy Networks  Vizient   Gretchen Brummel, PharmD, BCPS  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence    Host:  Carolyn Liptak, BS Pharmacy, MBA  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence    Show Notes:  [00:54-02:53] Mike Oinonen and Jordon Dow background information  [02:54-04:31] What exactly is a Chief Pharmacy Officer and how the CPO role differs from other types of health system pharmacy leaders [04:32-08:17] Gretchen and Mike discuss their blog post on the CPO role [08:18-07:46] Does the CPO role apply to all health systems in all hospitals big or small [07:47-12:11] How prevalent is this CPO role, and its history [12:12-15:42] Benefits of having a pharmacist at the C-suite level [15:42-19:03] What an organization is mission without a CPO [19:04-21:46] Where the CPO role is going in the future   Links | Resources: A Chief Pharmacy Officer in your C-suite: Vital to health system success  Vizient Pharmacy Solutions  Pharmacy Network  HVPE  ASHP Statement on the Roles and Responsibilities of the Pharmacy Executive  Rationale for having a chief pharmacy officer in a health care organization | American Journal of Health-System Pharmacy | Oxford Academic (oup.com)  The rise of the chief pharmacy officer    Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed

ACC 2024 Rapid Reaction: Part II Special Guest: Snehal Bhatt, PharmD, BCPS, FASHP, AACC @SnayCardsPharmD   04:05 – EMPACT-MI 29:35 – ULTIMATE-DAPT   Reference List: https://pharmacytodose.files.wordpress.com/2024/05/acc-2024-part-ii-references.pdf   PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Final Four Preview and More: 2024 Critical Care Trials March Madness Bracket   Sepsis/Fluids Bracketologist: Clay Small, PharmD, BCCCP CV/Pulm Bracketologist: Jolie Gallagher, PharmD, BCCCP Bleeding/BG Bracketologist: Jason Hecht, PharmD, BCPS, BCCCP, FCCM Neuro/PADIS Bracketologist: Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP   06:10 – Region recaps 32:10 – Final Four preview and predictions 45:30 – Revisiting pre-tournament predictions   PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf   Listener Bracket: https://pharmacytodose.com/2024/04/01/final-four-2024-critical-care-trials-march-madness-bracket-preview-and-recap/   2024 Critical Care Trials March Madness blank bracket: https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/   PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

2024 Critical Care Trials March Madness Bracket Preview: Part I Bleeding/Blood Glucose and Neuro/PADIS Regions   Bleeding/BG Bracketologist: Jason Hecht, PharmD, BCPS, BCCCP, FCCM Neuro/PADIS Bracketologist: Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP @karenccrx   PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf   2024 March Madness Bracket: https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/   PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

2024 SCCM Congress: Tuesday Special Guests: Karen Berger, PharmD, FASHP, FCCM, BCCCP, BCPS Melanie Smith Condeni, PharmD, FCCM, BCPS, BCCCP Julie Farrar, PharmD, BCCCP Lama Nazer, PharmD, BCPS Joanna Stollings, PharmD, FCCP, FCCM, BCPS, BCCCP Andy Webb, PharmD, BCCCP 03:05: Star Research Presentation: “Effect of Antipsychotics on Agitation in ICU Delirium: Secondary Analysis of a Randomized Trial” featuring Joanna Stollings 10:43: Star Research Presentations: “Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis (PRO-CAN)” & “Diagnostic and Prognostic Value of Procalcitonin in Critically Ill Cancer Patients with Sepsis” featuring Lama Nazer 25:32: Clinical Pharmacy and Pharmacology (CPP) Year in Review presenter and moderator roundtable discussion featuring Karen Berger, Melanie Smith Condeni, Julie Farrar, and Andy Webb 2024 SCCM Congress website: https://congress2024.sccm.org PharmacyToDose.com  @PharmacyToDose  PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Interviews with Leaders in Clinical Pharmacy: Leigh Ann Ross, Pharm.D., FCCP, FAPhA, FASHP, FNAP

John Armitstead, MS, RPh, FASHP, is the System Director of Pharmacy Services at Lee Health and a Past President of ASHP. Throughout his career John has been an avid proponent of continuous professional development (CPD). We talk through CPD including goals to set for yourself and how they change overtime as well as some philosophies of practice. This is a great episode to start off the new year as you are planning out new goals!

Jill Bates, PharmD, MS, BCOP, DipACLM, FASHP, is the Deputy Executive Director of the National Pharmacogenomics Program within the National Oncology Program Office of the Veterans Affairs (VA). Dr. Bates is an expert in oncology and pharmacogenomics and has led the VA's Pharmacogenomics program that is being rolled out nationwide. We talk through her background in both areas as well as the  VA's investment in pharmacogenomics and precision medicine. As part of their investment, they are hiring 120 pharmacists in this space across the country. Enjoy all things pharmaocgenomics in this episode! Below are article links of the VA's experience in pharmacogenomics. This article describes the VA's pilot PHASER program: Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program - PubMed (nih.gov)This article  reviews the VA's first PDSA cycle on pharmacogenomics implementation: Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program at initial test sites - PubMed (nih.gov)This article talks about the VA NPOP service and the importance of pharmacists within the precision oncology space: Oncology Pharmacists Help Bridge the Gap to Optimize Precision Oncology Services for Veterans With Cancer - PubMed (nih.gov)This article has an overview of the VA's PHASER program and other germline PGx programs throughout North Carolina: North Carolina's multi-institutional pharmacogenomics efforts with the North Carolina Precision Health Collaborative - PubMed (nih.gov)

Intranasal administration of medications is on the rise for both on and off label uses. Dr. Mark Donaldson, Associate Principal and Dr. Philippe Mentler Senior Consulting Director, both at Vizient join host Gretchen Brummel for two episodes, sharing details on these drugs, their actions and indications.   Guest speakers: Mark Donaldson, BSP, RPH, PHARMD, FASHP, FACHE Associate Principal Vizient Philippe Mentler, PHARMD, BCPS Senior Consulting Director Vizient Moderator: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence   Show Notes: [00:33 - 02:50] Why you would choose intra-nasal administration of an agent over some of the other non-oral or non-IV routes [02:51 - 6:05] Some practical considerations people should be aware of, particularly when not to use these agents [6:06 - 7:12] Some of the implications for the pediatric population [7:13 - 12:10] What we have to look forward to in the future in this space [12:11 - 13:46] What our frontline pharmacy staff should know about these medications   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed  

Intranasal administration of medications is on the rise for both on and off label uses. Dr. Mark Donaldson, Associate Principal and Dr. Phillipe Mentler Senior Consulting Director, both at Vizient join host Gretchen Brummel for two episodes, sharing details on these drugs, their actions and indications.   Guest speakers: Mark Donaldson, BSP, RPH, PHARMD, FASHP, FACHE Associate Principal Vizient Phillipe Mentler, PHARMD, BCPS Senior Consulting Director Vizient Moderator: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence   Show Notes: [01:16 - 03:46] Why the nose is a good target for medication administration [03:47 - 5:49] Some things you need to consider when administering medications intra-nasally [5:50 - 8:13] Some of the labeled and off-label intra-nasal medications and their indications [8:14 - 9:15] What we should be thinking about in terms of safety [9:16 - 10:06] Wrong route, have you seen that in your practice, or have there been reports of that in the literature [10:07 - 15:10] How some of these drugs are used in dental medicine   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed

Nish Kasbekar, PharmD, BSPharm, FASHP, is the President of the American Society of Health System Pharmacists (ASHP) and Chief Pharmacy Officer at the University of Pennsylvania Health System.Dr. Kasbekar talks through her priorities for ASHP this year, her path through professional organizations and her advice to those looking to get involved! Read the article from The Philadelphia Inquirer where they covered what an ICU Pharmacist does as Nish describes in the episode! More pharmacists should be in the news highlighting the great work they do everyday!

CancerNetwork® spoke with experts across multiple disciplines about the far-reaching impacts of the ongoing shortages of chemotherapy drugs including carboplatin and cisplatin, and how practices may be able to mitigate these challenges in the short and long term.  Michael Ganio, PharmD, MS, BCPS, FASHP, described the causes of carboplatin and cisplatin being in short supply across the United States and how the FDA is working with Chinese manufacturers to import these chemotherapy agents. Ganio, senior director of Pharmacy Practice and Quality at the American Society of Health-System Pharmacists, stated that communication is paramount among all members of a care team to help prevent critical errors while treating patients with limited supplies of these drugs. He also spoke about how reaching out to local representatives may help address the issues resulting from these shortages. “Advocacy is needed,” Ganio said. “Our policymakers need to know that these shortages are having a real-world impact, and that they need to be addressed.” Brian Slomovitz, MD, MS, FACOG, spoke about how he is managing the ongoing shortages in the context of his gynecologic cancer care, including swapping one platinum-based drug for another during treatment. Slomovitz, a gynecologic oncologist, director of Gynecologic Oncology, and co-chair of the Cancer Research Committee at Mount Sinai Medical Center in Miami Beach, Florida and a professor of Obstetrics and Gynecology at Florida International University, also described the challenges many practices across the country have due to lacking platinum-based drugs altogether. “I know there are institutions that don't have [platinum-based chemotherapy],” Slomovitz said. “There are institutions that aren't able to give their patients the best standard-of-care therapy and aren't able to enroll patients in trials because of lack of therapy.”  Lucio N. Gordan, MD, addressed the financial impacts of these shortages, discussing how his practice has managed the rising prices of carboplatin and cisplatin in the country. Gordan, president and managing physician at Florida Cancer Specialists & Research Institute who sees patients in the state-wide practice's Gainesville Cancer Center, stated that efforts from major oncology organizations may help increase adequate access to chemotherapy drugs. “It's very important that the large practices and institutions in the country stay united,” Gordan said. “The Community Oncology Alliance [COA], American Society of Clinical Oncology [ASCO], and others are trying to push legislation that would protect the consumer, the patients, and us to make sure that we have a proven supply.” Don't forget to subscribe to the “Oncology On-The-Go” podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.

On episode 35 with Dr. Megan Rech we dove into the reasons why clinical pharmacists are leaving health systems and on episode 53 with Dr. Alicia Lichvar we talked about the pressures on clinical pharmacists. This week I sat down with Dr. Bryan McCarthy Jr, System Director of Inpatient Pharmacy at Lifespan, to talk through how they are addressing the need for clinical pharmacist retention through a change in their practice model by including remote clinical pharmacists. You'll hear how the model works and how it's impacted their retention!

Dr. Rob T. Adamson PharmD, FASHP, Executive Vice President & Chief Information Officer and Operational Leader for the Epic Electronic Health Record implementation at RWJBaranas Health discusses delegation and employee when converting to Epic.

Presentations are a topic we are all familiar with and strive to improve upon. Whether it is for a discussion with your team and you are pitching an idea for a protocol or you are presenting at a national meeting, you want to be able to tell the story in a way that connects to the audience. We talk about ways to become a more effective presenter in this episode!Dave Hager, PharmD, BCPS, FASHP, is the Senior Director at Visante. He previously served as Director of Clinical Services at UW Health in Madison, WI. Dr. Hager is a frequent national and regional speaker. We talk through his four tips to a successful presentation and how to make your presentations more effective. There are so many good parts to this episode that it is one you can come back to time and time again!

Is there a better way to treat anxiety and depression for patients with cancer? C. Michael White, distinguished professor and chair of pharmacy practice at the University of Connecticut School of Pharmacy, considers the question. Michael White, Pharm.D., FCP, FCCP, FASHP has ~500 publications resulting in 16577 citations with an H-index of 67; placing him […]

In this podcast, Jeannell Mansur, R.Ph., Pharm.D., FASHP, FSMSO, CJCP, Principal Consultant for Medication Management and Safety with Joint Commission Resources will discuss the scope and significant changes to the revised USP Chapter and how it relates to the go-live for USP Chapter . Dr. Mansur will also provide recommendations for how hospitals can assess their compliance with these new requirements, as well as how the Joint Commission survey process will address these new requirements.This episode is sponsored by Joint Commission Resources.The use of Joint Commission Resources consultative technical or advisory services is not necessary to obtain a Joint Commission Accreditation award, nor does it influence the granting of such awards.

In this podcast, Jeannell Mansur, R.Ph., Pharm.D., FASHP, FSMSO, CJCP, Principal Consultant for Medication Management and Safety with Joint Commission Resources will discuss the scope and significant changes to the revised USP Chapter and how it relates to the go-live for USP Chapter . Dr. Mansur will also provide recommendations for how hospitals can assess their compliance with these new requirements, as well as how the Joint Commission survey process will address these new requirements.This episode is sponsored by Joint Commission Resources.

Benjamin J. Anderson, PharmD, MPH, FASHP and Diana J. Schreier, PharmD, MBA, BCPS recognize the history and regulations for prospective medication order review, describe the technical landscape for verification decision support and explore real-world verification decision support outcomes. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

This week we sit down with Alison Gulbis, PharmD, BCOP, Kamakshi Rao, PharmD, BCOP, FASHP, and Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA to discuss their work on the Oncology Workforce Collaborative. Alison is a Clinical Pharmacy Manager at the University of Texas MD Anderson Cancer Center in Houston, TX. She obtained her PharmD at the University of Florida and completed her PGY1 and PGY2 residencies at the Medical University of South Carolina. She has been in clinical practice for 19 years at MD Anderson and manages a team of clinical pharmacy specialists in pediatric hematology/oncology and adult stem cell transplant.Kamakshi is an Interim Director of Pharmacy at the University of North Carolina Medical Center in Chapel Hill. She oversees Adult Ambulatory and Acute Clinical Services as well as the hospital's academic enterprises, including resident and student training programs.  Additionally, she leads the department's growing efforts around diversity, equity, and inclusion. She spent 20 years in direct patient care, working with patients undergoing bone marrow transplants at the North Carolina Cancer Hospital before moving into her current role.Zahra is a Clinical Pharmacy Manager in the Division of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Health System (TUKHS). She earned her PharmD and MBA from the UMKC School of Pharmacy and the Henry W. Bloch School of Management. She completed residency training at The Ohio State University Medical Center and The Huntsman Cancer Institute at the University of Utah. She has been a board-certified oncology pharmacist since 2012. In 2022, she was the recipient of the ASTCT Pharmacy Special Interest Group Lifetime Achievement Award and ASCO's 40 Under 40 in Cancer award.You can read more here: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.1693

Applying the Just Culture Algorithm to Suspected Diversion Our guests: Becky Doerhoff, MSN, RN, CNL Director Patient Safety & Clinical PI, Barens Jewish Hospital Amanda Hays, PharmD, MHA, BCPS, CPHQ, FASHP , Director, Medical Affairs at BD A great discussion with Becky Doerhoff and Amanda Hays on how to utilize the Just Culture algorithm for suspected diversion. We give an overview of the Just Culture approach for those of you who are not familiar with it, and we talk about when it may or may not apply to an impaired healthcare professional or one who is suspected of diversion. They give some things to consider that many of you may not have contemplated previously. Thanks to our sponsor, IMI (International Medical Industries) Learn more about Prep Lock Tamper Evident Caps: https://imiweb.com/prep-lock-tamper-evident-caps-2/ For more information on Drug Diversion mitigation and resources, visit: https://www.rxpert.solutions/ #drugdiversion #hospitalpharmacy #opioidcrisis #hospitalworker

Paul Walker, PharmD, FASHP,  is the current President of the American Society of Health System Pharmacists (ASHP) and is a Clinical Professor and Assistant Dean of experiential education and community engagement at the University of Michigan College of Pharmacy and Manager in the Department of Pharmacy at Michigan Medicine. Dr. Walker describes his impactful year as President of ASHP as his theme of “Better Together” has resonated amongst the pharmacy community. He also talks through the next steps of ASHP's Task Force on DEI and the impact that having diverse representation in professional organizations has on our profession!

In this episode, co-authors of the recently released ASHP Guidelines on Preventing Diversion of Controlled Substances will discuss the changes to these guidelines as they impact data use and surveillance in the acute and non-acute care settings. They will share the updates to the guidelines and focus on the impact on data use for ongoing surveillance. Additionally, they will discuss the unique challenges of drug diversion prevention outside of acute care settings. HOST Amanda Hays, PharmD., MHA, BCPS, CPHQ, DPLA, FASHP Director, Medical Affairs, BD GUESTS Eric Maroyka, PharmD, BCPS Senior Director, Center Pharmacy Practice Advancement, ASHP Jordan Rush, PharmD, MS Director, System Retail & Outpatient Pharmacy, UNC Health Co-author, ASHP Revised Guidelines, Controlled Substance Diversion Kristi Gullickson, PharmD, MBA, FASHP, FMSHP, DLPA Director, Pharmacy and System Operations Lead, Allina Health at Abbot Northwestern Hospital Co-author, ASHP Revised Guidelines, Controlled Substance Diversion

Interviews with Leaders in Clinical Pharmacy: Marie Chisholm-Burns "It's all about access and success."

Julie L. Cunningham, PharmD, BCPP; M. Zeeshan Rizwan, PharmD, BCPS, BCCCP; Christi A. Jen, PharmD, BCPS, FASHP, FAzPA; and Kristina L. Wescott, PharmD, BCPS identify appropriate non-stigmatizing language related to opioids and addiction in the context of patient care discussions, discuss risks for opioid harms related to individual risks at points of transitions of patient care, review interventions for high-risk opioid patients across transitions of care and identify resources in multiple areas of practice to support patient care for opioid use. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

"Pharmacists on the Front Line of The Opioid Epidemic," by Randall W. Knoebel, PharmD, BCOP, Pharmacy Director of Health Analytics and Drug Policy,  Department of Pharmacy, University of Chicago Medicine, Chicago, Illinois; Chris Herndon, PharmD, BCACP, FASHP, FCCP, Professor, Department of Pharmacy Practice, Southern Illinois University Edwardsville School of Pharmacy, Edwardsville, Illinois; and David M. Dickerson, MD, Medical Director of Anesthesia Pain Management Services, NorthShore University HealthSystem, Chicago, Illinois. From ASRA Pain Medicine News, May 2022. See original article at www.asra.com/asra-news for figures and references. This material is copyrighted.         

Within the United States, reproductive rights have come back into the spotlight with the Supreme Court overturning Roe vs Wade. On this episode, I asked two friends and colleagues to join me in discussing reproductive health and rights, Kat Miller, PharmD, MHA, DPLA, FASHP, and Meghan Swarthout, PharmD, MBA, BCPS, FASHP. We talk through the healthcare implications around reproductive rights and how to get involved with advocacy. Many thanks to Kat and Meghan for having this conversation and talking through the next steps! 

• Mark Briesacher, Senior Vice President and Chief Physician Executive, Intermountain Healthcare• Robert J. Weber, PharmD, MS, BCPS, FASHP, Administrator, Pharmacy Services, Department of Pharmacy, The Ohio State University Wexner Medical Center • Tim Lynch, PharmD, MS, FABC, FASHP, FWSPA, Senior Vice President, Clinical Services, Multicare Health System • Moderated by Ayla Ellison, JD, Editor in Chief, Becker's Hospital Review

Jeff Little, PharmD, MHA, FASHP, FACHE, is the Director of Pharmacy and Outpatient Imaging at St. Luke's Hospital in Kansas City, MO. He served as the 2021-2022 ASHP Chair of the Section of Pharmacy Practice Leaders. Jeff has an extensive background in advocacy and focused the ASHP SPPL on advocacy this year. He talks through his experiences with congressional and state leaders and gives me advice on the Section for this next year!

On this week's episode, Suzy welcomes 2021 Women Pharmacist of the Year winners Nicole K Bookstaver, PharmD, BCACP; Seena L. Haines, PharmD, BCACP, NBS-HWC, CHWC, FAPhA, FCCP, FASHP, FNAP; Bled Nguessan, PharmD; and Dixie Leikach, RPh, MBA, FACA, to celebrate these honorable women and discuss key trends in pharmacy.

Rita Jew, PharmD, MBA, BCPPS, FASHP, is the President of the Institute of Safe Medication Practices (ISMP). Dr. Jew has over 30 years of pharmacy experience and has held many professional organization leadership positions. We discuss her vision for ISMP and how to make our medication systems safer!

Patricia (Patti) Kienle, BS Pharm, MPA, BCSCP, FASHP, is the Director of Accreditation and Medication Safety for Cardinal Health Innovative Delivery Solutions. She is the 2022 recipient of the Harvey A.K. Whitney Lecture Award, the highest honor in health-system pharmacy.  Patti is recognized as an expert on medication safety, hazardous drugs, and compounding practices. She is a member on the United States Pharmacopeia (USP) Compounding Expert Committee. Patti has received numerous awards in her career including the ISMP Lifetime Achievement Award and the ASHP John W Webb Lecture Award. You'll hear about her illustrious career, how she became involved in hospital pharmacy and medication safety, and her advice to young practitioners!

Michael Ganio, PharmD, MS, BCPS, FASHP, is the Senior Director of Pharmacy Practice and Quality at American Society of Health-System Pharmacists (ASHP).He was awarded the ASHP CEO Staff Excellence Award at the most recent ASHP Midyear Clinical Meeting. He's recognized as an expert on drug shortages, sterile and nonsterile compounding, and hazardous drug safety. Dr. Ganio is frequently interviewed by the media on pharmacy topics. He is a wealth of knowledge on all pharmacy practice quality initiatives!

Doina Dumitru, PharmD, MBA, FASHP is currently a Director of Professional Services at Becton Dickinson (BD), with responsibility over the national implementation teams for the Pharmogistics and BD Cato automation solutions. She completed her PharmD at the University of Illinois at Chicago College of Pharmacy and an executive MBA at the Lake Forest Graduate School of Management. Prior to joining BD, Dr. Dumitru spent many years in acute and ambulatory practice settings, including pharmacy informatics and hospital pharmacy leadership roles in Illinois and Texas. She is the author of The Pharmacy Informatics Primer, as well as multiple other informatics and hospital practice management publications and speaking engagements. Dr. Dumitru has served as a preceptor and lecturer for the University of Houston Health System Pharmacy Administrative residency program. In addition, Dr. Dumitru has served on many ASHP committees and councils on leadership and informatics, including her current appointment as a member of ASHP's SOPIT Education Steering Committee. --- Support this podcast: https://anchor.fm/freeman-means-business/support

Paul Szumita, Clinical Pharmacy Director at Brigham and Women's Hospital, shares how to participate in publishing research by working to fill gaps in the literature. Paul discusses with host Gretchen Brummel different types of publications that pharmacists get involved, some past projects of his own, training you need to publish, and how to get started in publishing work.   Guest speaker: Paul Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS    Director, Clinical Pharmacy Services Brigham and Women's Hospital   Moderator: Gretchen Brummel, PharmD, BCPS   Director, Clinical Pharmacy Services Vizient Center for Pharmacy Practice Excellence   Show Notes: [00:47-2:10] Paul's background and current position [02:11-2:47] Number one piece of advice to start publishing [02:48-4:42] Fitting publishing into day-to-day work [04:43-5:56] Different publications to get you involved [05:57-7:05] Paul's own projects [07:06-9:08] Barriers to publishing [09:09-10:04] Training needed [10:05-12:59] Process of submitting [13:00-14:41] Small scale ways to get started [14:42-18:43] Advantages to solo and team publishing [18:44-20:23] Future of pharmacy-based publication   Links | Resources: How-to guide for overcoming barriers of research and scholarship training in Pharm.D. and pharmacy residency programs Click here Residency research training: Need to rethink the prescription for success? Click here Barriers to publishing in biomedical journals perceived by a sample of French researchers: results of the DIAzePAM Click here   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Stitcher Android RSS Feed

Charles D. Ponte, BSc, PharmD, FADCES, FAPhA, FASHP, FCCP, FNAP, and Professor of Clinical Pharmacy and Family Medicine at West Virginia University discusses diabetes and pain management on the PQS Quality Corner Show.Host PQS Associate Director of Pharmacy Accounts of Pharmacy Accounts, Nick Dorich, PharmD asks Ponte about pain and discomfort for patients with diabetes, and Ponte talks specifically about neuropathic pain management.Pharmacist's Letter is offering CE credit for this podcast. Please log into your Pharmacist's Letter account and look for the title of this podcast in the list of available CE courses.

FacultyTyree H. Kiser, PharmD, FCCM, FCCP, BCCCP, BCPSProfessor, Department of Clinical PharmacyUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical SciencesCritical Care Pharmacy Specialist, Department of PharmacyUniversity of Colorado HospitalAurora, ColoradoCharles E. “Kurt” Mahan, PharmD, PhC, FASHP, FCCPAdjunct Associate Professor, PharmacyUniversity of New Mexico Health Sciences CenterAlbuquerque, New Mexico  Content based on a CE activity supported by an educational grant from Alexion, AstraZeneca Rare Disease.  Link to full activity: https://www.proce.com/Anticoagulation

Dr. Jason Goodchild, Vice President of Clinical Affairs at Premier Dental Products Company, and Dr. Mark Donaldson, Associate Principal in Pharmacy Advisory Solutions at Vizient discuss the merits of a recent statement on antibiotic prophylaxis for infective endocarditis with host Gretchen Brummel.   Guest speakers: Jason Goodchild, DMD Vice President of Clinical Affairs Premier Dental Products Company   Mark Donaldson, BSP, ACPR, PHARMD, FASHP, FACHE Associate Principal, Pharmacy Advisory Solutions Vizient   Moderator: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence   Show Notes: [00:53-1:55] Antibiotic prophylaxis against infective endocarditis as an important tool [01:56-2:48] Risks of over- or underutilization of this treatment modality [02:49-4:52] History of the guidelines [04:53-5:48] New statement impacts moving forward [05:49-8:49] Doxycycline as alternative to clindamycin in penicillin-allergic patients [08:50-9:47] The rationale to abandon clindamycin [09:48-11:49] How clindamycin compares to other agents [11:50-12:59] The bottom line   Links | Resources: Prevention of Viridans group Streptococcal infective endocarditis: a scientific statement from the American Heart Association: Click here Prevention of infective endocarditis: guidelines from the American Heart Association: Click here Antibiotic prophylaxis guidelines: is there new information for 2021? Click here   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Stitcher Android RSS Feed

James (Jim) Stevenson, PharmD, FASHP, FFIP, is the Chief Clinical Officer at Omnicell and Professor at the University of Michigan College of Pharmacy. He received the International Pharmaceutical Federation's (FIP) Distinguished Practice Award in 2021 for his work in the international pharmacy community.Dr. Stevenson and I talk about his work in international pharmacy as a member of FIP, his push for change of pharmacy's medication use systems that led him to Omnicell, and pharmacy's need for technology integration. This episode will speak to so many as he started his career with a passion for elevating clinical pharmacy. Whether you are interested in clinical, operations, technology, or international pharmacy, you'll find it in this episode. You'll see why he has been able to accomplish so much in his career!

According to the National Community Pharmacists Association (NCPA), community pharmacists are highly accessible health care professionals and 95% of Americans live within just 5 miles of a pharmacy. (https://ncpa.org/provider-status) And what APhA or American Pharmacist Association, the largest association of pharmacists in the US is doing is laser focusing on getting provider status for pharmacists. So why is that important when it comes to PGx as this is a PGx podcast? Pharmacists can order the PGx test when they see fit for their patients without the need of a clinician to sign that form.  Scott Knoer, MS, PharmD, FASHP, became the 13th Executive Vice President and Chief Executive Officer of the American Pharmacists Association in June 2020, after serving for nine years as the Chief Pharmacy Officer at the Cleveland Clinic. Dr. Knoer is a passionate advocate for patients and the profession of pharmacy. He has successfully lobbied boards of pharmacy in Ohio and Minnesota to allow the advancement of pharmacy practice, and he has led initiatives that changed Ohio and federal law related to the elevation of pharmacy practice and reducing the impact of drug shortages. He received his BA in psychology from Creighton University and his PharmD from the University of Nebraska. Learn more about your ad choices. Visit megaphone.fm/adchoices

According to the National Community Pharmacists Association (NCPA), community pharmacists are highly accessible health care professionals and 95% of Americans live within just 5 miles of a pharmacy. (https://ncpa.org/provider-status) And what APhA or American Pharmacist Association, the largest association of pharmacists in the US is doing is laser focusing on getting provider status for pharmacists. So why is that important when it comes to PGx as this is a PGx podcast? Pharmacists can order the PGx test when they see fit for their patients without the need of a clinician to sign that form.  Scott Knoer, MS, PharmD, FASHP, became the 13th Executive Vice President and Chief Executive Officer of the American Pharmacists Association in June 2020, after serving for nine years as the Chief Pharmacy Officer at the Cleveland Clinic. Dr. Knoer is a passionate advocate for patients and the profession of pharmacy. He has successfully lobbied boards of pharmacy in Ohio and Minnesota to allow the advancement of pharmacy practice, and he has led initiatives that changed Ohio and federal law related to the elevation of pharmacy practice and reducing the impact of drug shortages. He received his BA in psychology from Creighton University and his PharmD from the University of Nebraska. Learn more about your ad choices. Visit megaphone.fm/adchoices

According to the National Community Pharmacists Association (NCPA), community pharmacists are highly accessible health care professionals and 95% of Americans live within just 5 miles of a pharmacy. (https://ncpa.org/provider-status) And what APhA or American Pharmacist Association, the largest association of pharmacists in the US is doing is laser focusing on getting provider status for pharmacists. So why is that important when it comes to PGx as this is a PGx podcast? Pharmacists can order the PGx test when they see fit for their patients without the need of a clinician to sign that form.  Scott Knoer, MS, PharmD, FASHP, became the 13th Executive Vice President and Chief Executive Officer of the American Pharmacists Association in June 2020, after serving for nine years as the Chief Pharmacy Officer at the Cleveland Clinic. Dr. Knoer is a passionate advocate for patients and the profession of pharmacy. He has successfully lobbied boards of pharmacy in Ohio and Minnesota to allow the advancement of pharmacy practice, and he has led initiatives that changed Ohio and federal law related to the elevation of pharmacy practice and reducing the impact of drug shortages. He received his BA in psychology from Creighton University and his PharmD from the University of Nebraska. Learn more about your ad choices. Visit megaphone.fm/adchoices

On today's episode of The PQI Podcast we welcome Howard Cohen, RPh, MS, FASHP. Howard recently retired as the Executive Director of Oncology Pharmacy Services for the Smilow Cancer Hospital and Network of Yale New Haven Health.  He is also the President of Safe Medication Management Associates, Inc. and serves as a consultant for Grifols. He earned his Bachelor of Science degree in pharmacy from the University of Kansas and his Master of Science degree from Temple University School of Pharmacy in Philadelphia, Pa. He completed an Executive Management fellowship at the Wharton School of Business. In 1995 he received the designation of Fellow of the American Society of Health-System Pharmacists. In 2014, the Smilow Cancer Hospital Pharmacy was honored as the recipient of ASHP Foundations Award for Medication Safety and Use.  Today we discuss the use of robotic technology in oncology pharmacy.  

On this episode of Leadership Lessons in Health-System Pharmacy you will hear from Kenneth Jozefczyk, MS, RPh, FASHP, Director of Centralized Pharmacy Services for the 15-hospital BayCare Health System in the Tampa Bay region of Florida. Join us as we discuss extemporaneously compounded pharmaceuticals and a 503B facility experience in a pharmacy enterprise. Prior to joining BayCare, Ken was Director of Pharmacy at both Memorial Health University Medical Center in Savannah, Georgia and at West Virginia University Hospitals, and Assistant Director at the Medical University of South Carolina. He received his B.S. in Pharmacy from Wayne State University and is a proud graduate of the MS/Residency program at The Ohio State University and The Ohio State University Hospitals. He has been recognized with multiple honors including the Jack L. Beal Postbaccalaureate Award, the GSHP Pharmacist of the Year and most notably the 2012 Clifton J. Latiolais Award.

In this episode, our guest is Dr. Leigh Ann Ross who is the Associate Dean for Clinical Affairs at the University of Mississippi School of Pharmacy and Professor in the Department of Pharmacy Practice. She previously served as the Chair of the Department of Pharmacy Practice and currently serves as Director of the Center for Clinical and Translational Science and Research Professor in the Research Institute of Pharmaceutical Sciences at UM. Dr. Ross also works with the John D. Bower School of Population Health at the University of Mississippi Medical Center as a Professor in the Department of Population Health Science. Dr. Ross received a Bachelor of Business Administration and a Doctor of Pharmacy from Ole Miss. She completed a Primary Care Pharmacy Residency at UMMC. Since joining the faculty in 2009, Dr. Ross has led practice initiatives to implement medication management services at the Medical Center and in communities through UM's Community-Based Research Program. In addition to her work in pharmacy, Dr. Ross completed a 2-year Congressional Fellowship in the Office of U.S. Senator Thad Cochran where she served as policy advisor on health care and also worked on labor, housing, and economic development. Dr. Ross is a graduate of Leadership Mississippi and has been actively involved in professional organizations at a state and national level. She is a Past President of the Mississippi Pharmacists Association and current President- Elect of the American College of Clinical Pharmacy. Dr. Ross is passionate about leadership development and advocacy within our profession. Key points: Service - I love professional service and I feel it is important to encourage our students and early career pharmacists to be involved in professional organizations. I have worked with most all professional organizations over the last 20 years, but my current focus is as President-Elect of ACCP and member of their Board of Regents. Leadership - I am passionate about leadership development. I appreciate the mentorship provided to me in this area and have tried to incorporate this into our curriculum for both students and residents. Advocacy - I feel advocacy to move pharmacy forward is very important. I have enjoyed building on my experience as a Health Policy Fellow and working with others to better understand legislative processes and how to advocate for our profession. Practice Advancement / Community-Based Research - I had the opportunity early in my career to lead the Pharmaceutical Care Clinics at UMMC, comprised of pharmacist-run clinics and interprofessional clinics and later to work with colleagues to implement a Community-Based Research Program to implement medication management services (like those in the Pharmaceutical Care Clinics) in community pharmacy and clinic settings. Through the Community-Based Research Program, we have established a number of partnerships, such as the Mississippi State Department of Health. Research - Most recently, I worked with colleagues to establish a Center for Clinical and Translational Science in our Research Institute. This Center is structured to facilitate research across the translational spectrum from basic research to clinical trials to communities. Our community research is now housed in this Center. Guest - Leigh Ann Ross, PharmD, BCPS, FASHP, FCCP, FAPhA, FNAP Host - Hillary Blackburn, PharmD, MBA www.hillaryblackburn.com https://www.linkedin.com/in/hillary-blackburn-67a92421/ @talktoyourpharmacist for Instagram and Facebook @HillBlackburn Twitter

Pharmacy dashboards are no longer enough. To manage organizational complexity and make better informed decisions, pharmacy leaders need dynamic intelligence tools. Learn how emerging technologies, including predictive and prescriptive analytics, can take medication management to the next level. Guests:                      Jennifer Tryon, PharmD, MS, FASHP, Associate Vice President and Chief Pharmacy Officer, Wake Forest Baptist Health Allen Flynn, PharmD, PhD, Assistant Professor, Department of Learning Health Science, University of Michigan Medical School Host:                          Ken Perez, Vice President, Healthcare Policy and Government Affairs, Omnicell See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacy dashboards are no longer enough. To manage organizational complexity and make better informed decisions, pharmacy leaders need dynamic intelligence tools. Learn how emerging technologies, including predictive and prescriptive analytics, can take medication management to the next level. Guests:                      Jennifer Tryon, PharmD, MS, FASHP, Associate Vice President and Chief Pharmacy Officer, Wake Forest Baptist Health Allen Flynn, PharmD, PhD, Assistant Professor, Department of Learning Health Science, University of Michigan Medical School Host:                          Ken Perez, Vice President, Healthcare Policy and Government Affairs, Omnicell See omnystudio.com/listener for privacy information.

Pharmacy dashboards are no longer enough. To manage organizational complexity and make better informed decisions, pharmacy leaders need dynamic intelligence tools. Learn how emerging technologies, including predictive and prescriptive analytics, can take medication management to the next level. Guests:                      Jennifer Tryon, PharmD, MS, FASHP, Associate Vice President and Chief Pharmacy Officer, Wake Forest Baptist Health Allen Flynn, PharmD, PhD, Assistant Professor, Department of Learning Health Science, University of Michigan Medical School Host:                          Ken Perez, Vice President, Healthcare Policy and Government Affairs, Omnicell See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Linda Tyler, PharmD, FASHP, is the current President of the American Society of Health-System Pharmacists (ASHP). She recently retired from her role as Chief Pharmacy Officer at the University of Utah Health Care and will be transitioning to Professor at the University of Utah College of Pharmacy this fall. Dr. Tyler highlights her inaugural ASHP Presidential address (https://www.ashp.org/About-ASHP/Our-Leadership/President-Bio) and what she is focused on for ASHP this year. Learn more about Linda's career path and why she went into leadership. Dr. Tyler's calm and poised nature, paired with her passions, is so admirable and you'll hear that throughout the podcast!

Lindsey Kelley, PharmD, MS, FASHP, is Director of Pharmacy at Michigan Medicine and serves as Director-at-Large for ASHP's Section of Pharmacy Practice Leaders. Dr. Kelley is an advocate for diversity, equity, and inclusion (DEI) initiatives. This episode is the essence of why this podcast was started. It's a natural conversation that includes DEI, building up those around you, and creating opportunities for others. Learn how Lindsey determines what requests to say yes to and which ones to say no to. This podcast was recorded on the day Derek Chauvin's verdict was announced, which led us into deeper conversations around privilege and white supremacy. It's a conversation that we need to continue to have and I'm so thankful Dr. Kelley was wiling to have it with me. It's one you don't want to miss!

This podcast will provide information on continuous professional development (CPD) and its importance to practitioners. The podcast will also provide perspectives from pharmacy leaders on the value and importance of ASHP's Fellows (FASHP) and how achievement is recognition of longitudinal commitment to practice advancement. Additionally, the podcast will explain how utilization of the FASHP guidelines for application can serve as a road map for CPD. Navigating Purposeful Career Growth: Using the FASHP Criteria to Lead Your CPD Updated on July 14, 2021. An earlier version of this podcast has been edited to clarify the interpretation of criterion 2 and criterion 4 of the ASHP Practitioner Recognition Program. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Larry Buie, PharmD, BCOP, FASHP, is the current President of the Hematology/Oncology Pharmacy Association (HOPA) and the Manager for Clinical Pharmacy Practice and PGY2 Residency Program Director at Memorial Sloane Kettering Cancer Center.Dr. Buie and Dr. Amerine talk through burnout in clinicians, Larry's transition from clinician to leader, how he manages his clinical team, and how he's changed his precepting style over the years. He'll discuss HOPA's strategic priorities over the next year and the task forces created to achieve the priorities. As we celebrate Pride month, hear Larry's thoughts on how we make our organizations and spaces around us more inclusive.

It's just food. Or just a beverage. You don't need to worry about whether it will affect your milk or your baby, right? Or, maybe you should worry? Heck, maybe you're already worried, but perhaps there's nothing to worry about! Get answers about safety, side effects, allergies and more as Marie interviews her guest, Philip O. Anderson, PharmD, FASHP, FCSHP, the author of the National Library of Medicine's LactMed database. They'll talk about the research to substantiate answers to questions about food and beverages that you probably consume on a regular basis, as well as some foods you might never have heard of. Listen as Marie asks Dr. Anderson about the effects of coffee, tea, colas, chocolate, alcohol, garlic, onions, cauliflower, broccoli, mushrooms, fava beans, turtle meat, and more! Are you curious about food allergies, maternal vaccinations while breastfeeding, food poisoning, botulism and breastfeeding? Get the information you need on those topics, too!

Welcome to Unscripted! I'm Lindsey Amerine, PharmD, MS, BCPS, FASHP. I'll introduce the podcast in this episode. Become a part of the unscripted community where we can be ourselves and cover diverse topics through great conversation.

Dr. Kelly Smith is the Dean of the University of Georgia College of Pharmacy. She is a past President of ASHP (American Society of Health-System Pharmacists) and has won numerous awards in her career including Pharmacist of the Year from the Kentucky Society of Health-System Pharmacists. Dr. Smith and Dr. Amerine talk about them both being introverts, the power of authenticity, Kelly's time as ASHP President including how she had to end Magic Johnson's keynote and her meeting Michelle Obama. We talk about her role as Dean of UGA's College of Pharmacy and her overall career path. She has been a “catalyst of others” throughout her career and continues to do so in her role as Dean.

Sandra Leal is the President of the APhA and is a longtime advocate and leader for #providerstatus, Sandra has had a tremendous impact on the profession and we are honored to have her on the Pharmacy Podcast. Sandra is committed to the theme & mission for pharmacists to "Be the Voice for Pharmacy" and she asks that you join her in her mission by speaking up and using your voices too. CONNECT w/ SANDRA  @SLealRx @BetheVoiceRx Scott Knoer, PharmD is the CEO of the APhA and is committed to changing the payment system of the strangle-hold status quo system controlled by the 3 leading PBMs which process more than 75% of all prescriptions in the U.S.  CONNECT w/ SCOTT  @ScottKnoer The American Pharmacists Association (APhA) has joined a federal lawsuit filed by the National Community Pharmacists Association (NCPA) in January to challenge direct and indirect remuneration (DIR) fees. DIR fees have been a point of contention since they were loosely established in 2014 because they allow pharmacy benefit managers (PBMs) to retroactively impose these fees on pharmacies and, indirectly, on patients long after the point of sale. “HHS has acknowledged on multiple occasions that retroactive pharmacy DIR fees inflict harm on pharmacies and increase costs for their patients, but it has repeatedly neglected to address the problem,” said APhA EVP and CEO Scott J. Knoer, MS, PharmD, FASHP, in a press release. “This lawsuit puts pharmacy in the driver's seat. We demand that HHS meet its obligations and use its authority to stop PBMs from operating without accountability.” Scott was interviewed by Pharmacy Times Alana Hippensteele & said:  Right now, obviously, doctors, PAs, nurse practitioners, and—this is no insult intended whatsoever—but audiologists and nurse midwives are also providers. Pharmacists are the second most educated with PharmD's and our bachelor's pharmacists have been working 30 years with experience, and my audiologist, I have a hearing tested—God love her—she did a great job, but she's not trained at the level pharmacists are. So it's just ludicrous that pharmacists cannot bill for the services they all went to school for. So—we'll get to this, I know you've got your questions, I'm sorry I give long answers to short questions—the problem is pharmacies are only reimbursed for product in the community setting, and 20 years ago that was okay because you got paid enough where I could talk to your mom about her diabetes. Now the PBMs have sucked so much money out of the health care system without providing any real value that all you can do is volume. That's why we've had reporter—just recently Adiel Kaplan at NBC news—talk about the challenges in chain pharmacies. I love chain pharmacies, but they tend to have busier pharmacies, people are stressed out, they're burned out, they're worried about making errors—so that was a long answer to what's this do—it allows for patients in underserved areas where—it's not everyone, but it's a good start—for pharmacists to bill for what they went to school for. For a sustainable practice model—it's not sustainable right now. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Sandra Leal is the President of the APhA and is a longtime advocate and leader for #providerstatus, Sandra has had a tremendous impact on the profession and we are honored to have her on the Pharmacy Podcast. Sandra is committed to the theme & mission for pharmacists to "Be the Voice for Pharmacy" and she asks that you join her in her mission by speaking up and using your voices too. CONNECT w/ SANDRA  @SLealRx @BetheVoiceRx Scott Knoer, PharmD is the CEO of the APhA and is committed to changing the payment system of the strangle-hold status quo system controlled by the 3 leading PBMs which process more than 75% of all prescriptions in the U.S.  CONNECT w/ SCOTT  @ScottKnoer The American Pharmacists Association (APhA) has joined a federal lawsuit filed by the National Community Pharmacists Association (NCPA) in January to challenge direct and indirect remuneration (DIR) fees. DIR fees have been a point of contention since they were loosely established in 2014 because they allow pharmacy benefit managers (PBMs) to retroactively impose these fees on pharmacies and, indirectly, on patients long after the point of sale. “HHS has acknowledged on multiple occasions that retroactive pharmacy DIR fees inflict harm on pharmacies and increase costs for their patients, but it has repeatedly neglected to address the problem,” said APhA EVP and CEO Scott J. Knoer, MS, PharmD, FASHP, in a press release. “This lawsuit puts pharmacy in the driver’s seat. We demand that HHS meet its obligations and use its authority to stop PBMs from operating without accountability.” Scott was interviewed by Pharmacy Times Alana Hippensteele & said:  Right now, obviously, doctors, PAs, nurse practitioners, and—this is no insult intended whatsoever—but audiologists and nurse midwives are also providers. Pharmacists are the second most educated with PharmD's and our bachelor's pharmacists have been working 30 years with experience, and my audiologist, I have a hearing tested—God love her—she did a great job, but she's not trained at the level pharmacists are. So it's just ludicrous that pharmacists cannot bill for the services they all went to school for. So—we'll get to this, I know you've got your questions, I'm sorry I give long answers to short questions—the problem is pharmacies are only reimbursed for product in the community setting, and 20 years ago that was okay because you got paid enough where I could talk to your mom about her diabetes. Now the PBMs have sucked so much money out of the health care system without providing any real value that all you can do is volume. That's why we've had reporter—just recently Adiel Kaplan at NBC news—talk about the challenges in chain pharmacies. I love chain pharmacies, but they tend to have busier pharmacies, people are stressed out, they're burned out, they're worried about making errors—so that was a long answer to what's this do—it allows for patients in underserved areas where—it's not everyone, but it's a good start—for pharmacists to bill for what they went to school for. For a sustainable practice model—it's not sustainable right now. See omnystudio.com/listener for privacy information.

In this episode of the Pharmacy Leaders series podcast, host, Bruce Scott MS, FASHP, along with Katherine Miller, Pharm.D., MBA, DPLA, FASHP, and Brandy Snyder, Pharm.D., BCOP, MBA, DPLA discusses how to make the most of your leadership journey.  This podcast will explore high performing teams and leadership development. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Updates in COVID-19 Pharmacotherapy Special Guests: Amy Dzierba, PharmD, FCCM, FCCP, BCCCP Mitchell Buckley, PharmD, FASHP, FCCM, FCCP, BCCP   Show Notes: https://pharmacytodose.files.wordpress.com/2021/04/covid19-show-notes.pdf   Reference List: https://pharmacytodose.files.wordpress.com/2021/04/covid19-references.pdf   03:25 – Tocilizumab; 22:21 – Corticosteroids; 37:50 – Anticoagulation; 72:50 – Potpourri/Take-home points   PharmacyToDose.Com @PharmacyToDose on Twitter PharmacyToDose@Gmail.com

In this episode of the Pharmacy Leaders series podcast, host, Sara White, MS, FASHP, discusses finding mentors to help you grow, learn and develop as a leader and putting those leadership traits into practice. The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode of the Pharmacy Leaders series podcast, host, Sara White, MS, FASHP, along with Kimberly Boler BS, CPhT, CSPT, DPLA, and Sam Calabrese MBA, FASHP discusses the role of pharmacy technicians as leaders. This podcast explores whether leaders are born or made and the non-negotiable qualities of a successful leader. The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician

On Episode 9 of Leadership Lessons in Health-System Pharmacy, you will hear from Paul W. Abramowitz, Pharm.D., Sc.D. (Hon), FASHP, Chief Executive Officer of the American Society of Health-System Pharmacists (ASHP), as we discuss the role of a pharmacy professional organization in managing the COVID-19 pandemic. Prior to joining ASHP in September 2011, Dr. Abramowitz worked in hospitals and health-systems for 34 year. He served as Associate Hospital Director for Professional Services and Chief Pharmacy Officer at the University of Iowa Hospitals and Clinics, and Professor at the University of Iowa College of Pharmacy. In addition to serving as Treasurer of ASHP from 2007-10 and as ASHP President in 1993-94, he has chaired several boards. Dr. Abramowitz received a Bachelors Degree in Chemistry and Biology from Indiana University, a Bachelors Degree in Pharmacy from the University of Toledo, a Pharm.D. from the University of Michigan, and completed his residency at the University of Michigan Medical Center. Dr. Abramowitz has actively combined practice, teaching, and research throughout his career. He is a recipient of many awards and recognitions, including, but not limited to: the John W. Webb Lecture Award, the Harvey A.K. Whitney Lecture Award, and in 2013 the Honorary Degree of Doctor of Science from the University of Toledo. In 2015, he was recognized as one of Washington's Trending Association Leaders by Bisnow. Currently, Dr. Abramowitz serves on the Boards of the American Nurses Foundation, the Pharmacy Technician Certification Board and the GTMRx Institute. He also is a member of the National Steering Committee for Patient Safety of the Institute for Healthcare Improvement and a Professor-Emeritus at the University of Iowa. His lectures and publications have focused on topics such as: the effect that pharmacists have on improving outcomes of care and reducing costs; developing new care models; reducing adverse drug events; and expanding comprehensive medication management to the ambulatory setting.

Owning your role in difficult situations, building iterative self improvement, embracing feedback, and much more, with emergency pharmacist, toxicologist, and professor at Harvard medical school Bryan Hayes, PharmD, DABAT, FAACT, FASHP.

The Future of Pharmacy Podcast, presented by Omnicell Every day it seems, health system pharmacy leaders face new challenges. Learn how the Autonomous Pharmacy is intended to simplify medication management, and enable pharmacists and other clinicians to practice at the top of their licenses. Host: Ken Perez Vice President, Healthcare Policy, Omnicell Guests: Jennifer Tryon, PharmD, MS, FASHP Associate Vice President and Chief Pharmacy  Officer, Wake Forest Baptist Health Jim Stevenson, PharmD, FASHP, FFIP Vice President, Medication System Strategy, Omnicell See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Future of Pharmacy Podcast, presented by Omnicell Every day it seems, health system pharmacy leaders face new challenges. Learn how the Autonomous Pharmacy is intended to simplify medication management, and enable pharmacists and other clinicians to practice at the top of their licenses. Host: Ken Perez Vice President, Healthcare Policy, Omnicell Guests: Jennifer Tryon, PharmD, MS, FASHP Associate Vice President and Chief Pharmacy  Officer, Wake Forest Baptist Health Jim Stevenson, PharmD, FASHP, FFIP Vice President, Medication System Strategy, Omnicell See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Niesha Griffith, RPh, MS, FASHP, interim chief pharmacy officer and executive director at a freestanding cancer center on the West Coast, and Michael Ganio, PharmD, MS, BCPS, FASHP, director of pharmacy practice and quality, American Society of Hospital Pharmacists (ASHP), provide varying perspectives on the potential of drug shortages (eg, pain medications, cancer therapies, and hydroxychloroquine) emerging during the COVID-19 pandemic, as well as how the supply chain functions through the ASHP when a shortage is identified.

In this episode of LambTaLKS, Justine and Sara welcome Dr. Jennifer Brandt PharmD, RPh, FASHP. Dr. Jennifer Brandt currently works at Washington Hospital Center as a Clinical Specialist in Critical Care and Clinical Resource Utilization. She completed her residency there and graduated from the University of Rhode Island where she joined Lambda Kappa Sigma Xi chapter. She is currently an Epsilon Alumni chapter member and has served LKS in numerous ways: as Past Grand President, Grand President, Grand Treasurer, Grand VP for Alumni, and as a Region Supervisor. She received the Distinguished Young Pharmacist Award in 2008 as well as the LKS/Merk & Co. Vanguard Leadership Award in 2019. If you would like to get in contact with Dr. Brandt, you can email her at jennybrandt1@gmail.com. We would like to thank the sisters who have made this podcast possible with their donations that paid for our wonderful sound equipment: Dixie Leikach, Christine Perry, Jennifer Rhodes, Ruth Brown, Justine Dickson, and Sara Kheboian. To learn more about Lambda Kappa Sigma or LambTaLKS, visit LKS.org. Please forward any feedback or questions to LambTaLKSPodcast@lks.org. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

It's just food. Or just a beverage. You don't need to worry about whether it will affect your milk or your baby, right? Or, maybe you should worry? Heck, maybe you're already worried, but perhaps there's nothing to worry about! Get answers about safety, side effects, allergies and more as Marie interviews her guest, Philip O. Anderson, PharmD, FASHP, FCSHP, the author of the National Library of Medicine's LactMed database. They'll talk about the research to substantiate answers to questions about food and beverages that you probably consume on a regular basis, as well as some foods you might never have heard of. Listen as Marie asks Dr. Anderson about the effects of coffee, tea, colas, chocolate, alcohol, garlic, onions, cauliflower, broccoli, mushrooms, fava beans, turtle meat, and more! Are you curious about food allergies, maternal vaccinations while breastfeeding, food poisoning, botulism and breastfeeding? Get the information you need on those topics, too!

Avadim Health Podcast Series Part One:  the Pain Factor with Special Guest Jeffrey Fudin, B.S., Pharm.D., FCCP, FASHP, FFSMB and Ralph Lombardo SVP of Sales and Marketing of Avadim Health.  Avadim Health identifies unmet needs and addresses them in a way nobody has, with a portfolio of advanced, safe solutions and a strong pipeline across a broad range of health and wellness areas. Whether we're developing products aimed to improve health and enhance quality of life or helping communities through local and global philanthropy efforts, our mission is to serve. It's in our name—Avadim meaning “servants”—and it's a responsibility we don't take lightly. At Avadim Health, we are committed to ensuring the quality and safety of our products, as well as delivering the best possible health and wellness outcomes. Our products are non-toxic, safe for daily use, and produced in an FDA regulatory and compliant drug and medical device manufacturing facility in the United States. About our special guest:  Jeffrey Fudin, B.S., Pharm.D., FCCP, FASHP, FFSMB Diplomate, Academy of Integrative Pain Management Founder and CEO, REMITIGATE, LLC in Delmar NY Director PGY2 Pain Residency Stratton VA Medical Center in Albany NY Adjunct Associate Professor, Western New England University College of Pharmacy Adjunct Assistant Professor of Pharmacy Practice, University of Connecticut School of Pharmacy Section Editor, Pain Medicine Owner & Managing Editor, PainDr.com Dr. Fudin graduated from Albany College of Pharmacy & Health Sciences with his Bachelors Degree and Pharm.D. He completed an Oncology/Hematology fellowship at SUNY/Upstate Medical Center. He is a Diplomate to the Academy of Integrative Pain Management and a Fellow to the American College of Clinical Pharmacy, the American Society of Health-system Pharmacists, and the Federation of State Medical Board. http://paindr.com/meet-dr-fudin/ See omnystudio.com/listener for privacy information.

In this episode, you'll hear from a healthcare leader who is a recognized expert in the 340B program. Chris Hatwig, M.S., R.Ph., FASHP, serves as the President of Apexus, which is the Prime Vendor Program for the 340B program. Chris has kept taking opportunities which have led to his long success as a 340B thought leader. #340BProgram #SafetyNet #Pharmacy Check out the show notes here: www.pharmacyadvisory.com★ Support this podcast on Patreon ★

In this episode, you'll hear from a pharmacist who's positioned herself as a leading healthcare executive as a former COO of a hospital and now a VP at a healthcare company. Erin Hendrick, PharmD, BCPS, FASHP, shares how she first developed her clinical leadership skills first and built upon those. Dr. Hendrick emphasizes the importance of staying connected to colleagues and seeking advice from mentors, as well as realigning priorities depending on what your goals are and what is happening at your stage of life. As a healthcare executive with Shields Healthcare, she focuses on building specialty pharmacy practices, which is a service line that many hospitals are expanding. Check out the show notes: www.pharmacyadvisory.com Connect with Erin Hendrick at Shields Health Solutions: http://www.shieldshealthsolutions.com/erin-hendrick/★ Support this podcast on Patreon ★

Today's Pharmacy Podcast Show guest is Dr. Jeffrey Fudin. We're talking about the March 30th 2016 article from Pain News Network:  How Opioid Prescribing Guidelines Use Pseudoscience By Michael Schatman and Jeffrey Fudin, Guest Columnists Recently, we (along with our colleague, Dr. Jacqueline Pratt Cleary) published an open access article in the Journal of Pain Research, entitled “The MEDD Myth: The Impact of Pseudoscience on Pain Research and Prescribing Guideline Development.” In this work, we address the issue of how governmental and managed care opioid guideline prescribing committees use the flawed concept of morphine-equivalent daily dose (MEDD or MME) to arbitrarily place limits on the amount of opioids that a clinician “should” prescribe to any patient with chronic pain -- as if all patients were identical.  The article cites excellent research that exposes the invalid concept of MEDD – and while guideline authors are fully aware of that lack of evidence, they are hypocritically fine with using MEDD as a device to thwart chronic opioid use. In the case of opioids for chronic non-cancer pain, there is at least some evidence.  But for MEDD, there is no evidence. About:  Jeffrey Fudin, BS, PharmD, DAAPM, FCCP, FASHP   Dr. Jeff Fudin graduated from Albany College of Pharmacy & Health Sciences with a bachelor's degree and PharmD. He is a Diplomate to the American Academy of Pain Management, a Fellow to ACCP, a Fellow to ASHP, and a member of several other professional organizations. He is founder and CEO of Remitigate, LLC (remitigate.com), a software platform for interpreting urine drug screens (Urintel) and pharmacogenetics(Phenotel).   Dr. Fudin is a section editor for Pain Medicine and serves on the editorial board for Practical Pain Management. He is founder/chairman of Professionals for Rational Opioid Monitoring & Pharmacotherapy (PROMPT), an advocacy group in favor of safe opioid prescribing. He practices as a clinical pharmacy specialist and director of PGY-2 pharmacy pain residency programs at the Stratton Veterans Administration Medical Center in Albany, New York. He is an adjunct associate professor of pharmacy practice at Western New England University College of Pharmacy and an adjunct assistant professor of pharmacy practice at the University of Connecticut School of Pharmacy.   Dr. Fudin can also be found at his professional website, www.paindr.com. Contact Info:  Dr. Jeffrey Fudin  Email: jeff@paindr.com Twitter: @JeffreyFudin LinkedIn: linkedin.com/in/jeffreyfudin See omnystudio.com/listener for privacy information.